CDSCO panel tells Serum Institute of India on Dengue Tetravalent Vaccine
New Delhi: Regarding the Phase I/II clinical trial of Dengue Tetravalent Vaccine (Live, Attenuated), the Subject Expert Committee (SEC) functional ...
New Delhi: Regarding the Phase I/II clinical trial of Dengue Tetravalent Vaccine (Live, Attenuated), the Subject Expert Committee (SEC) functional ...
Here are the top health stories for the day:NMC gives deadline to FMGE June 2023 candidates applying for eligibility certificateReferring ...
Here are the top health stories for the day:Serum Institute of India launches first made-in-India HPV vaccine for cervical cancerChief ...
© Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical News Hubb All rights reserved.